AKBA

Akebia Therapeutics, Inc. -

$1.40+0.02 (+1.4%)

via yahooMkt cap cached about 10 hours ago

Key statistics

Market cap

375.6M

Forward P/E

-7.4

EPS

$-0.08

Revenue

$232.4M

Profit margin

-8.8%

Beta

0.23

Volume

2.9M

Avg volume

5.1M

Analyst view

Buy

Trading ranges

Day range$1.38 to $1.42

52-week range$0.82 to $4.04

Price chart

Advanced TradingView chart with indicators and drawing tools.

TradingView

Fundamentals

Market cap

375.6M

Revenue (TTM)

$232.4M

EPS

$-0.08

Profit margin

-8.8%

Live metrics via Yahoo Finance.

Latest news

Recent company headlines for research context.

Finnhub

Loading news...

Financials and filings

Official filing data with consensus earnings context.

EPS estimates vs actuals

Period	Est.	Actual	Surprise
2025-06-30	-0.02	0.00	+100.0%
2025-09-30	-0.02	0.00	+100.0%
2025-12-31	-0.03	-0.05	-96.1%
2026-03-31	-0.03	-0.03	-4.9%

Loading financials...

Stoa coverage

No Stoa coverage on AKBA yet

When an analyst publishes a call or report on this ticker, it will show up here.

Financials and filings

Official filing data with consensus earnings context.

EPS estimates vs actuals

Period	Est.	Actual	Surprise
2025-06-30	-0.02	0.00	+100.0%
2025-09-30	-0.02	0.00	+100.0%
2025-12-31	-0.03	-0.05	-96.1%
2026-03-31	-0.03	-0.03	-4.9%